Viewing Study NCT01890135


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-03-02 @ 4:01 PM
Study NCT ID: NCT01890135
Status: COMPLETED
Last Update Posted: 2016-08-02
First Post: 2013-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication
Sponsor: University of Virginia
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral Arterial Disease View
None Intermittent Claudication View
Keywords:

Keywords

Keyword Brief Keyword Text View
None randomized View
None double blind View
None blood flow View
None muscle perfusion View
None safety View